Kinetic information from dynamic contrast-enhanced MRI enables prediction of residual cancer burden and prognosis in triple-negative breast cancer: a retrospective study

Abstract This study aimed to evaluate the predictions of dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) for prognosis of triple-negative breast cancer (TNBC), especially with residual disease (RD) after preoperative chemotherapy. This retrospective analysis included 74 TNBC patients...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Ayane Yamaguchi, Maya Honda, Hiroshi Ishiguro, Masako Kataoka, Tatsuki R. Kataoka, Hanako Shimizu, Masae Torii, Yukiko Mori, Nobuko Kawaguchi-Sakita, Kentaro Ueno, Masahiro Kawashima, Masahiro Takada, Eiji Suzuki, Yuji Nakamoto, Kosuke Kawaguchi, Masakazu Toi
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/50ca524a075a42ba86b159a9b55637d5
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:50ca524a075a42ba86b159a9b55637d5
record_format dspace
spelling oai:doaj.org-article:50ca524a075a42ba86b159a9b55637d52021-12-02T15:55:13ZKinetic information from dynamic contrast-enhanced MRI enables prediction of residual cancer burden and prognosis in triple-negative breast cancer: a retrospective study10.1038/s41598-021-89380-42045-2322https://doaj.org/article/50ca524a075a42ba86b159a9b55637d52021-05-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-89380-4https://doaj.org/toc/2045-2322Abstract This study aimed to evaluate the predictions of dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) for prognosis of triple-negative breast cancer (TNBC), especially with residual disease (RD) after preoperative chemotherapy. This retrospective analysis included 74 TNBC patients who received preoperative chemotherapy. DCE-MRI findings from three timepoints were examined: at diagnosis (MRIpre), at midpoint (MRImid) and after chemotherapy (MRIpost). These findings included cancer lesion size, washout index (WI) as a kinetic parameter using the difference in signal intensity between early and delayed phases, and time-signal intensity curve types. Distant disease-free survival was analysed using the log-rank test to compare RD group with and without a fast-washout curve. The diagnostic performance of DCE-MRI findings, including positive predictive value (PPV) for pathological responses, was also calculated. RD without fast washout curve was a significantly better prognostic factor, both at MRImid and MRIpost (hazard ratio = 0.092, 0.098, p < 0.05). PPV for pathological complete remission at MRImid was 76.7% by the cut-off point at negative WI value or lesion size = 0, and 66.7% at lesion size = 0. WI and curve types derived from DCE-MRI at the midpoint of preoperative chemotherapy can help not only assess tumour response but also predict prognosis.Ayane YamaguchiMaya HondaHiroshi IshiguroMasako KataokaTatsuki R. KataokaHanako ShimizuMasae ToriiYukiko MoriNobuko Kawaguchi-SakitaKentaro UenoMasahiro KawashimaMasahiro TakadaEiji SuzukiYuji NakamotoKosuke KawaguchiMasakazu ToiNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-11 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Ayane Yamaguchi
Maya Honda
Hiroshi Ishiguro
Masako Kataoka
Tatsuki R. Kataoka
Hanako Shimizu
Masae Torii
Yukiko Mori
Nobuko Kawaguchi-Sakita
Kentaro Ueno
Masahiro Kawashima
Masahiro Takada
Eiji Suzuki
Yuji Nakamoto
Kosuke Kawaguchi
Masakazu Toi
Kinetic information from dynamic contrast-enhanced MRI enables prediction of residual cancer burden and prognosis in triple-negative breast cancer: a retrospective study
description Abstract This study aimed to evaluate the predictions of dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) for prognosis of triple-negative breast cancer (TNBC), especially with residual disease (RD) after preoperative chemotherapy. This retrospective analysis included 74 TNBC patients who received preoperative chemotherapy. DCE-MRI findings from three timepoints were examined: at diagnosis (MRIpre), at midpoint (MRImid) and after chemotherapy (MRIpost). These findings included cancer lesion size, washout index (WI) as a kinetic parameter using the difference in signal intensity between early and delayed phases, and time-signal intensity curve types. Distant disease-free survival was analysed using the log-rank test to compare RD group with and without a fast-washout curve. The diagnostic performance of DCE-MRI findings, including positive predictive value (PPV) for pathological responses, was also calculated. RD without fast washout curve was a significantly better prognostic factor, both at MRImid and MRIpost (hazard ratio = 0.092, 0.098, p < 0.05). PPV for pathological complete remission at MRImid was 76.7% by the cut-off point at negative WI value or lesion size = 0, and 66.7% at lesion size = 0. WI and curve types derived from DCE-MRI at the midpoint of preoperative chemotherapy can help not only assess tumour response but also predict prognosis.
format article
author Ayane Yamaguchi
Maya Honda
Hiroshi Ishiguro
Masako Kataoka
Tatsuki R. Kataoka
Hanako Shimizu
Masae Torii
Yukiko Mori
Nobuko Kawaguchi-Sakita
Kentaro Ueno
Masahiro Kawashima
Masahiro Takada
Eiji Suzuki
Yuji Nakamoto
Kosuke Kawaguchi
Masakazu Toi
author_facet Ayane Yamaguchi
Maya Honda
Hiroshi Ishiguro
Masako Kataoka
Tatsuki R. Kataoka
Hanako Shimizu
Masae Torii
Yukiko Mori
Nobuko Kawaguchi-Sakita
Kentaro Ueno
Masahiro Kawashima
Masahiro Takada
Eiji Suzuki
Yuji Nakamoto
Kosuke Kawaguchi
Masakazu Toi
author_sort Ayane Yamaguchi
title Kinetic information from dynamic contrast-enhanced MRI enables prediction of residual cancer burden and prognosis in triple-negative breast cancer: a retrospective study
title_short Kinetic information from dynamic contrast-enhanced MRI enables prediction of residual cancer burden and prognosis in triple-negative breast cancer: a retrospective study
title_full Kinetic information from dynamic contrast-enhanced MRI enables prediction of residual cancer burden and prognosis in triple-negative breast cancer: a retrospective study
title_fullStr Kinetic information from dynamic contrast-enhanced MRI enables prediction of residual cancer burden and prognosis in triple-negative breast cancer: a retrospective study
title_full_unstemmed Kinetic information from dynamic contrast-enhanced MRI enables prediction of residual cancer burden and prognosis in triple-negative breast cancer: a retrospective study
title_sort kinetic information from dynamic contrast-enhanced mri enables prediction of residual cancer burden and prognosis in triple-negative breast cancer: a retrospective study
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/50ca524a075a42ba86b159a9b55637d5
work_keys_str_mv AT ayaneyamaguchi kineticinformationfromdynamiccontrastenhancedmrienablespredictionofresidualcancerburdenandprognosisintriplenegativebreastcanceraretrospectivestudy
AT mayahonda kineticinformationfromdynamiccontrastenhancedmrienablespredictionofresidualcancerburdenandprognosisintriplenegativebreastcanceraretrospectivestudy
AT hiroshiishiguro kineticinformationfromdynamiccontrastenhancedmrienablespredictionofresidualcancerburdenandprognosisintriplenegativebreastcanceraretrospectivestudy
AT masakokataoka kineticinformationfromdynamiccontrastenhancedmrienablespredictionofresidualcancerburdenandprognosisintriplenegativebreastcanceraretrospectivestudy
AT tatsukirkataoka kineticinformationfromdynamiccontrastenhancedmrienablespredictionofresidualcancerburdenandprognosisintriplenegativebreastcanceraretrospectivestudy
AT hanakoshimizu kineticinformationfromdynamiccontrastenhancedmrienablespredictionofresidualcancerburdenandprognosisintriplenegativebreastcanceraretrospectivestudy
AT masaetorii kineticinformationfromdynamiccontrastenhancedmrienablespredictionofresidualcancerburdenandprognosisintriplenegativebreastcanceraretrospectivestudy
AT yukikomori kineticinformationfromdynamiccontrastenhancedmrienablespredictionofresidualcancerburdenandprognosisintriplenegativebreastcanceraretrospectivestudy
AT nobukokawaguchisakita kineticinformationfromdynamiccontrastenhancedmrienablespredictionofresidualcancerburdenandprognosisintriplenegativebreastcanceraretrospectivestudy
AT kentaroueno kineticinformationfromdynamiccontrastenhancedmrienablespredictionofresidualcancerburdenandprognosisintriplenegativebreastcanceraretrospectivestudy
AT masahirokawashima kineticinformationfromdynamiccontrastenhancedmrienablespredictionofresidualcancerburdenandprognosisintriplenegativebreastcanceraretrospectivestudy
AT masahirotakada kineticinformationfromdynamiccontrastenhancedmrienablespredictionofresidualcancerburdenandprognosisintriplenegativebreastcanceraretrospectivestudy
AT eijisuzuki kineticinformationfromdynamiccontrastenhancedmrienablespredictionofresidualcancerburdenandprognosisintriplenegativebreastcanceraretrospectivestudy
AT yujinakamoto kineticinformationfromdynamiccontrastenhancedmrienablespredictionofresidualcancerburdenandprognosisintriplenegativebreastcanceraretrospectivestudy
AT kosukekawaguchi kineticinformationfromdynamiccontrastenhancedmrienablespredictionofresidualcancerburdenandprognosisintriplenegativebreastcanceraretrospectivestudy
AT masakazutoi kineticinformationfromdynamiccontrastenhancedmrienablespredictionofresidualcancerburdenandprognosisintriplenegativebreastcanceraretrospectivestudy
_version_ 1718385390635712512